Crossmark

ERX-41; Promising compound by targeting LIPA is a new Achilles heel therapeutic strategy for hard-to-treat solid tumors by induction of endoplasmic reticulum stress

Crossref DOI link: https://doi.org/10.1016/j.vacun.2023.06.004

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Eslami, Majid

Memarian, Mohammad

Yousefi, Bahman
License Information

Text and Data Mining valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: ERX-41; Promising compound by targeting LIPA is a new Achilles heel therapeutic strategy for hard-to-treat solid tumors by induction of endoplasmic reticulum stress

Journal Title: Vacunas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacun.2023.06.004

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below